US20030023140A1 - Pathlength corrected oximeter and the like - Google Patents
Pathlength corrected oximeter and the like Download PDFInfo
- Publication number
- US20030023140A1 US20030023140A1 US10/174,482 US17448202A US2003023140A1 US 20030023140 A1 US20030023140 A1 US 20030023140A1 US 17448202 A US17448202 A US 17448202A US 2003023140 A1 US2003023140 A1 US 2003023140A1
- Authority
- US
- United States
- Prior art keywords
- light
- detector
- spectrophotometer
- tissue
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000010363 phase shift Effects 0.000 claims abstract description 44
- 230000001766 physiological effect Effects 0.000 claims abstract description 23
- 230000005012 migration Effects 0.000 claims abstract description 19
- 238000013508 migration Methods 0.000 claims abstract description 19
- 238000001514 detection method Methods 0.000 claims description 51
- 230000003287 optical effect Effects 0.000 claims description 16
- 230000005855 radiation Effects 0.000 claims description 9
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 230000031700 light absorption Effects 0.000 claims description 2
- 108010054147 Hemoglobins Proteins 0.000 description 11
- 102000001554 Hemoglobins Human genes 0.000 description 11
- 238000010586 diagram Methods 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000036675 Myoglobin Human genes 0.000 description 2
- 108010062374 Myoglobin Proteins 0.000 description 2
- 108010064719 Oxyhemoglobins Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 108010002255 deoxyhemoglobin Proteins 0.000 description 1
- 230000023077 detection of light stimulus Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/41—Devices for promoting penis erection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N21/3151—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using two sources of radiation of different wavelengths
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
- A61B2562/0242—Special features of optical sensors or probes classified in A61B5/00 for varying or adjusting the optical path length in the tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/043—Arrangements of multiple sensors of the same type in a linear array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/41—Devices for promoting penis erection
- A61F2005/411—Penile supports
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J9/00—Measuring optical phase difference; Determining degree of coherence; Measuring optical wavelength
- G01J9/04—Measuring optical phase difference; Determining degree of coherence; Measuring optical wavelength by beating two waves of a same source but of different frequency and measuring the phase shift of the lower frequency obtained
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N2021/1789—Time resolved
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N2021/1789—Time resolved
- G01N2021/1791—Time resolved stroboscopic; pulse gated; time range gated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/314—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
- G01N2021/3181—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using LEDs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/061—Sources
- G01N2201/06113—Coherent sources; lasers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/069—Supply of sources
- G01N2201/0696—Pulsed
Definitions
- the present invention relates to a wearable tissue spectrophotometer for in vivo examination of tissue of a specific target region.
- Continuous wave (CW) tissue oximeters have been widely used to determine in vivo concentration of an optically absorbing pigment (e.g., hemoglobin, oxyhemoglobin) in biological tissue.
- the CW oximeters measure attenuation of continuous light in the tissue and evaluate the concentration based on the Beer Lambert equation or modified Beer Lambert absorbance equation.
- the CW spectrophotometric techniques can not determine ⁇ , C, and ⁇ L> at the same time. If one could assume that the photon pathlength were constant and uniform throughout all subjects, direct quantitation of the constituent concentration (C) using CW oximeters would be possible.
- the optical migration pathlength varies with the size, structure, and physiology of the internal tissue examined by the CW oximeters.
- the gray and white matter and the structures thereof are different in various individuals.
- the photon migration pathlength itself is a function of the relative concentration of absorbing constituents.
- the pathlength through an organ with a high blood hemoglobin concentration for example, will be different from the same with a low blood hemoglobin concentration.
- the pathlength is frequently dependent upon the wavelength of the light since the absorption coefficient of many tissue constituents is wavelength dependent. Thus, where possible, it is advantageous to measure the pathlength directly when quantifying the hemoglobin concentration in tissue.
- the present invention is a pathlength corrected oximeter that utilizes principles of continuous wave spectroscopy and phase modulation spectroscopy.
- the oximeter is a compact unit constructed to be worn by a subject on the body over long periods of activity.
- the oximeter is also suitable for tissue monitoring in critical care facilities, in operating rooms while undergoing surgery or in trauma related situations.
- the oximeter is mounted on a body-conformable support structure placed on the skin.
- the support structure encapsulates several light emitting diodes (LEDs) generating light of different wavelengths introduced into the examined tissue and several photodiode detectors with interference filters for wavelength specific detection. Since both the LEDs and the photodiodes are placed directly on the skin, there is no need to use optical fibers.
- the distance between the LEDs and the diode detectors is selected to examine a targeted tissue region.
- the support structure also includes a conformable barrier, located between the LEDs and the diode detectors, designed to reduce detection of light that migrates subcutaneously from the source to the detector.
- the support structure may further include means for preventing escape of photons from the skin without being detected; the photon escape preventing means are located around the LEDs and the photodiode detectors.
- the LEDs, the diode detectors, and the electronic control circuitry of the oximeter are powered by a battery pack adapted to be worn on the body or by the standard 50/60 Hz supply.
- the electronic circuitry includes a processor for directing operation of the sources, the detectors and for directing the data acquisition and processing.
- the data may be displayed on a readout device worn by the user, sent by telemetry to a remote location or accumulated in a memory for later use.
- the oximeter is adapted to measure the attenuation of light migrating from the source to the detector and also to determine the average migration pathlength. The migration pathlength and the intensity attenuation data are then used for direct quantitation of a tissue property.
- the invention is a spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, including
- an oscillator adapted to generate a carrier waveform of a selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port; a light source, operatively connected to the oscillator, adapted to generate light of a selected wavelength that is intensity modulated at the frequency and introduced to a subject at the input port; a photodiode detector adapted to detect, at the detection port, light of the selected wavelength that has migrated in the tissue of the subject between the input and detection ports; a phase detector, operatively connected to receive signals from the oscillator and the diode detector, adapted to measure a phase shift between the introduced and the detected light; and a processor adapted to calculate pathlength based on the phase shift, and determine a physiological property of the examined tissue based on the pathlength.
- the invention is a spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, including an oscillator adapted to generate a carrier waveform of a selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port; a light source, operatively connected to the oscillator, adapted to generate light of a selected wavelength that is intensity modulated at the frequency and introduced to a subject at the input port; a photodiode detector adapted to detect, at the detection port, light of the selected wavelength that has migrated in the tissue of the subject between the input and detection ports; a phase splitter adapted to produce, based on the carrier waveform, first and second reference phase signals of predefined substantially different phase; first and second double balanced mixers adapted to correlate the reference phase signals and signals of the detected radiation to produce therefrom a real output signal and an imaginary output signal, respectively; and a processor adapted to calculate, on the basis of the real output signal and the imaginary
- the invention is a spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, comprising a first oscillator adapted to generate a carrier waveform of a first selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port; a light source, operatively connected to the oscillator, adapted to generate light of a selected wavelength, intensity modulated at the first frequency, that is introduced to a subject at the input port; a photodiode detector adapted to detect, at the detection port, light of the wavelength that has migrated in the tissue of the subject between the input and detection ports, the detector producing a detection signal at the first frequency corresponding to the detected light; a second oscillator adapted to generate a carrier waveform of a second frequency that is offset on the order of 10 4 Hz from the first frequency; a reference mixer, connected to the first and second oscillators, adapted to generate a reference signal of a frequency approximately equal to
- Preferred embodiments of these aspects may include one or more of the following features.
- the spectrophotometer may further include a magnitude detector, connected to the photodiode detector, adapted to measure magnitude of the detected light, and the processor is further adapted to receive the magnitude for determination of the physiological property.
- the spectrophotometer may further include a low frequency oximeter circuit, switchably connected to the source and the photodiode, adapted to determine absorption of light at the wavelength; and the processor is further adapted to receive absorption values from the oximeter circuit for determination of the physiological property.
- the spectrophotometer may further include two automatic gain controls adapted to level signals corresponding to the introduced light and the detected light, both the leveled signals being introduced to the phase detector.
- the photodiode detector may further include a substantially single wavelength filter.
- the spectrophotometer may further include a second light source, operatively connected to the oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a second input port; the photodiode detector further adapted to detect alternately, at the detection port, light of the first and second wavelengths that have migrated in the tissue of the subject between the first and the second input ports and the detection port, respectively; the phase detector further adapted to receive alternately signals corresponding to the detected first and second wavelengths; and the processor further adapted to receive alternately phase shifts from the phase detector, the phase shifts being subsequently used for determination of the physiological property of the tissue.
- a second light source operatively connected to the oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a second input port
- the photodiode detector further adapted to detect alternately, at the detection port, light of the first and second wavelengths
- the spectrophotometer may further include a second light source, operatively connected to the oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a second input port; a second photodiode detector adapted to detect, at a second detection port, light of the second wavelength that has migrated in the tissue of the subject between the second input port and the second detection port, respectively; a second phase detector, operatively connected to receive a reference signal and a detection signal from the third diode detector, adapted to measure a phase shift between the introduced and the detected light at the second wavelength; and the processor further adapted to receive a second phase shift at the second wavelength, the first and second phase shifts being subsequently used for determination of the physiological property of the tissue.
- a second light source operatively connected to the oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a second input port
- the two wavelength spectrophotometer may further include a third light source, operatively connected to the oscillator, adapted to generate light of a third selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a third input port; a third photodiode detector adapted to detect, at a third detection port, light of the third wavelength that has migrated in the tissue of the subject between the third input port and the third detection port, respectively; a third phase detector, operatively connected to receive a reference signal and a detection signal from the third diode detector, adapted to measure a phase shift between the introduced and the detected light at the third wavelength; and the processor further adapted to receive phase shifts from the phase detector, the first second and third phase shifts being subsequently used for determination of the physiological property of the tissue.
- a third light source operatively connected to the oscillator, adapted to generate light of a third selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a third input port
- the two or three wavelength spectrophotometer may further include a first, a second (or a third) magnitude detector connected to the first, second (or third) photodiode detectors, respectively, the magnitude detectors being adapted to measure magnitude of the detected light at each of the wavelengths; and the processor further adapted to receive the magnitudes for determination of the physiological property of the tissue.
- the light source may be a light emitting diode for generating light of a selected wavelength in the visible or infra-red range.
- the photodiode detector may be a PIN diode or an avalanche diode.
- the examined physiological property of the tissue may be hemoglobin oxygenation, myoglobin, cytochrome iron and copper, melanin, glucose or other.
- FIG. 1 is a block diagram of a pathlength corrected oximeter in accordance with the present invention.
- FIG. 2 is a schematic circuit diagram of a 50.1 MHz (50.125 MHz) oscillator used in the oximeter of FIG. 1.
- FIG. 3 is a schematic circuit diagram of a PIN diode and a preamplifier used in the oximeter of FIG. 1.
- FIG. 4 is a schematic circuit diagram of a magnitude detector used in the oximeter of FIG. 1.
- FIG. 5 is a schematic circuit diagram of a 25 kHz filter used in the oximeter of FIG. 1.
- FIG. 6 is a schematic diagram of an AGC circuit of the oximeter of FIG. 1.
- FIG. 7 is a schematic circuit diagram of a phase detector of the oximeter of FIG. 1.
- FIG. 8A is a plan view of a source-detector probe of the oximeter.
- FIG. 8B is a transverse cross-sectional view taken on lines 8 B of FIG. 8A further showing the photon migration.
- One preferred embodiment of the pathlength corrected oximeter utilizes three LEDs for generation of light at three selected wavelengths intensity modulated at a frequency of 50.1 MHz and coupled directly to the examined tissue. At each wavelength, the introduced light is altered by the tissue and is detected by a wide area photodiode placed against the skin. The introduced and detected radiations are compared to determine their relative phase shift that corresponds to an average pathlength of the migrating photons and, furthermore, the light attenuation is determined.
- the oximeter includes a master oscillator 10 operating at 50.1 MHz connected to a power amplifier 15 of sufficient output power to drive LEDs 22 a , 22 b , and 22 c (for example HLP 20RG or HLP 40RG made by Hitachi) that emit 760 nm, 840 nm, and 905 nm (or 950 nm) light, respectively.
- a second local oscillator 14 operating at 50.125 MHz and mixer 12 are used to generate a reference frequency 13 of 25 kHz.
- Each LED directly positioned on the skin has an appropriate heat sink to eliminate uncomfortable temperature increases that could also alter blood perfusion of the surrounding tissue.
- Three PIN diode detectors 24 a , 24 b , and 24 c are placed at a distance of approximately 5 cm from the LEDs and have a detection area of about 1 cm 2 . Photons migrating a few centimeters deep into the tissue are detected by the respective PIN diodes. The source-detector separation can be increased or decreased to capture deeper or shallower migrating photons.
- the signals from PIN diodes 24 a , 24 b , and 24 c are amplified by preamplifiers 30 a , 30 b , and 30 c , respectively.
- the amplified signals ( 32 a , 32 b , 32 c ) are sent to magnitude detectors 36 a , 36 b , and 36 c and to mixers 40 a , 40 b , and 40 c , respectively.
- the magnitude detectors are used to determine intensity values of detected signals at each wavelength to be used in Eq. 1.
- Each mixer connected to receive a 50.125 MHz reference signal ( 41 a , 41 b , 41 c ) from local oscillator 14 , converts the detection signal to a 25 kHz frequency signal ( 42 a , 42 b , 42 c ).
- the mixers are high dynamic range frequency mixers, model SRA-1H, commercially available from Mini-Circuits (Brooklyn N.Y.).
- the detection signals ( 42 a , 42 b , and 42 c ) are filtered by filters 45 a , 45 b , 45 c , respectively.
- Phase detectors 60 a , 60 b , and 60 c are used to determine phase shift between the input signal and the detected signal at each wavelength.
- Each phase detector receives the 25 kHz detection signal ( 54 a , 54 b , 54 c ) and the 25 kHz reference signal ( 56 a , 56 b , 56 c ), both of which are automatically leveled by automatic gain controls 50 and 52 to cover the dynamic range of signal changes.
- Phase detectors 60 a , 60 b , and 60 c generate phase shift signals ( 62 a , 62 b , 62 c ) corresponding to the migration delay of photons at each wavelength.
- Each phase shift signal is proportional to the migration pathlength used in calculation algorithms performed by processor 70 .
- FIG. 2 shows a schematic circuit diagram of a precision oscillator used as the 50.1 MHz master oscillator 10 and 50.125 MHz local oscillator 14 .
- the oscillator crystals are neutralized for operation in the fundamental resonance mode; this achieves long-term stability.
- Both oscillators are thermally coupled so that their frequency difference is maintained constant at 25 kHz if a frequency drift occurs.
- PIN diodes 24 a , 24 b , and 24 c are directly connected to their respective preamplifiers 30 a , 30 b , and 30 c , as shown in FIG. 3.
- the oximeter uses PIN silicon photodiodes S1723-04 with 10 mm ⁇ 10 mm sensitive area and spectral response in the range of 320 nm to 1060 nm.
- the detection signal is amplified by stages 29 and 31 , each providing about 20 dB amplification.
- the NE5205N operational amplifier is powered at +8V to operate in a high gain regime.
- the 8V signal is supplied by a voltage regulator 33 .
- the amplified detection signals ( 32 a , 32 b , and 32 c ) are sent to magnitude detectors 36 a , 36 b , and 36 c , shown in FIG. 4.
- the magnitude values ( 37 a , 37 b , and 37 c ) are sent to processor 70 that calculates the light attenuation ratio or logarithm thereof as shown Eq. 1.
- the AGC circuit uses MC 1350 integrated circuit for amplification that maintains the input signal of phase detector 60 at substantially constant levels.
- the amount of gain is selected to be equal for AGCs, 50 and 52 .
- the signal amplitude is controlled by a feedback network 53 .
- the AGCs provide a substantially constant amplitude of the detected and reference signals to eliminate variations in the detected phase shift due to cross talk between amplitude and phase changes in the phase detector.
- each phase detector includes a Schmitt trigger that converts the substantially sinusoidal detection signal ( 54 a , 54 b , 54 c ) and reference signal ( 56 a , 56 b , 56 c ) to square waves.
- the square waves are input to a detector that has complementary MOS silicon-gate transistors.
- the phase shift signal is sent to processor 70 .
- the oximeter is calibrated by measuring the phase shift for a selected distance in a known medium, i.e., using a standard delay unit, and by switching the length of a connector wire to change the electrical delay between master oscillator 10 and local oscillator 14 .
- source-detector probe 20 includes several LEDs ( 22 a , 22 b , 22 c ) of selected wavelengths and PIN photodiodes ( 24 a , 24 b , 24 c ) mounted in a body-conformable support structure 21 .
- Structure 21 also includes a photon escape barrier 27 made of a material with selected scattering and absorption properties (for example, styrofoam) designed to return escaping photons back to the examined tissue.
- the support structure further includes a second conformable barrier 28 , located between the LEDs and the diode detectors, designed to absorb photons directly propagating from the source to the detector and thus prevent detection of photons that migrate subcutaneously.
- Support structure 21 also includes electronic circuitry 29 encapsulated by an electronic shield 21 a.
- Each PIN diode is provided with an evaporated single wavelength film filter ( 25 a , 25 b , 25 c ).
- the filters eliminate the cross talk of different wavelength signals and allow continuous operation of the three light sources, i.e., no time sharing is needed.
- photodiode detectors has substantial advantages when compared with the photomultiplier tube used in standard phase modulation systems.
- the photodiodes are placed directly on the skin, i.e., no optical fibers are needed. Furthermore, there is no need to use a high voltage power supply that is necessary for the photomultiplier tube.
- the photodiodes are much smaller and are easy to place close to the skin. Advantages of the photomultiplier tube are a huge multiplication gain and a possibility of direct mixing at the photomultiplier; this cannot be achieved directly by a photodiode.
- This invention envisions the use of several different photodiodes such as PIN diode, avalanche diode, and other.
- the processor uses algorithms that are based on equations described by E. M. Sevick et al. in “Quantitation of Time- and Frequency-Resolved Optical Spectra for the Determination of Tissue Oxygenation” published in Analytical Biochemistry 195, 330 Apr. 15, 1991 which is incorporated by reference as if fully set forth herein.
- f is modulation frequency of the introduced light which is in the range of 10 MHz to 100 MHz; t ⁇ is the photon migration delay time; c is the speed of photons in the scattering medium; and L ⁇ is the migration pathlength.
- Equation (2) is valid at low modulation frequencies, i.e., 2 ⁇ f ⁇ a ⁇ c.
- the modulation frequency of 50 MHz was selected due to the frequency limitation of the LEDs and photodiodes. However, for faster LEDs and photodiodes it may be desirable to use higher modulation frequencies that increase the phase shift.
- the phase shift is no longer proportional to the mean time of flight ⁇ t>.
- ⁇ ⁇ a ⁇ ⁇ ⁇ ⁇ ( 1 - g ) ⁇ ⁇ s ⁇ f ⁇ ⁇ 1 - ⁇ a ⁇ ⁇ c 4 ⁇ ⁇ ⁇ ⁇ f ⁇ ( 3 )
- ⁇ is the source-detector separation
- (1 ⁇ g) ⁇ s is effective scattering coefficient
- f is modulation frequency
- ⁇ a ⁇ is absorption coefficient at wavelength ⁇ .
- ⁇ 0 ⁇ represents background scattering and absorption.
- the wavelengths are in the visible and infra-red range and are selected to have absorbance sensitive (or insensitive) to various tissue components such as water, cytochrome iron and copper, oxy- and deoxygenated forms of hemoglobin, myoglobin, melanin, glucose and other.
- ⁇ Hb ⁇ 1 and ⁇ Hb0 ⁇ 1 are extinction coefficients for hemoglobin and deoxyhemoglobin that can be stored in a look up table; [Hb], [HbO 2 ] are the tissue concentration of hemoglobin and oxyhemoglobin, respectively; ⁇ ⁇ 1 is background absorbance.
- processor 70 determines Y based on Eq. (7) using Eq. (2) to determine the average migration pathlength L that is then used in Eq. (1) and to determine ⁇ a ⁇ for each wavelength ⁇ 1 , ⁇ 2 , ⁇ 3 .
- the spectrophotometer's electronics includes a low frequency module suitably and a high frequency module switchably coupled to the same source-detector probe 20 .
- the low frequency module and the arrangement of the source-detector probe are substantially similar to the hemoglobinometer described in a copending U.S. patent application Ser. No. 701,127 filed May 16, 1991 which is incorporated by reference as if fully set forth herein.
- the low frequency module corresponds to a standard oximeter with modulation frequencies in the range of a few hertz to 10 4 hertz and is adapted to provide intensity attenuation data at two or three wavelengths.
- the LEDs are switched to the high frequency phase modulation unit, similar to the unit of FIG. 1, which determines the average pathlength at each wavelength.
- the attenuation and pathlength data are sent to processor 70 for determination of a physiological property of the examined tissue.
- the pathlength corrected oximeter utilizes the same LED sources ( 22 a , 22 b , 22 c ) sinusoidally modulated at a selected frequency comparable to the average migration time of photons scattered in the examined tissue on paths from the optical input port of the LED's to the optical detection part of the photodiode detectors ( 24 a , 24 b , 24 c ), but the electronic circuitry is different.
- the detector output is put through two wide band double balance mixers (DBM) which are coupled through a 90° phase splitter so that real (R) and imaginary (I) portions of the signal are obtained.
- the double balance mixers preferably operate at the modulation frequency.
- the phase ( ⁇ ⁇ ) is the angle whose tangent is the imaginary over the real part.
- ⁇ ⁇ tan - 1 ⁇ I ⁇ R ⁇ ( 8 )
- the amplitude is the square root of the sum of the squares of these values, providing the phase shift has been taken out as the residual phase shift ⁇ set to zero.
- This embodiment uses summing and dividing circuits to calculate the modulation index, which is the quotient of the amplitude over the amplitude plus the DC component obtained from a narrow band detector.
- M ⁇ A ⁇ A ⁇ + D ⁇ ⁇ C ⁇ ( 10 )
- the phase processor receives the phase shifts for the phase and amplitude values for two or three wavelengths and calculates the ratio of the phase shifts.
- the phase shift and the DC amplitude are used to determine a selected tissue property, e.g., hemoglobin oxygenation.
Abstract
A pathlength corrected spectrophotometer for tissue examination includes an oscillator for generating a carrier waveform of a selected frequency, an LED light source for generating light of a selected wavelength that is intensity modulated at the selected frequency introduced to a subject, and a photodiode detector for detecting light that has migrated in the tissue of the subject. The spectrophotometer also includes a phase detector for measuring a phase shift between the introduced and detected light, a magnitude detector for determination of light attenuation in the examined tissue, and a processor adapted to calculate the photon migration pathlength and determine a physiological property of the examined tissue based on the pathlength and on the attenuation data.
Description
- This application is a continuation-in-part of application Ser. No. 07/645,590 filed Jan. 24, 1991 incorporated by reference as if fully set forth herein.
- The present invention relates to a wearable tissue spectrophotometer for in vivo examination of tissue of a specific target region.
- Continuous wave (CW) tissue oximeters have been widely used to determine in vivo concentration of an optically absorbing pigment (e.g., hemoglobin, oxyhemoglobin) in biological tissue. The CW oximeters measure attenuation of continuous light in the tissue and evaluate the concentration based on the Beer Lambert equation or modified Beer Lambert absorbance equation. The Beer Lambert equation (1) describes the relationship between the concentration of an absorbent constituent (C), the extinction coefficient (ε), the photon migration pathlength <L>, and the attenuated light intensity (I/Io).
- The CW spectrophotometric techniques can not determine ε, C, and <L> at the same time. If one could assume that the photon pathlength were constant and uniform throughout all subjects, direct quantitation of the constituent concentration (C) using CW oximeters would be possible.
- In tissue, the optical migration pathlength varies with the size, structure, and physiology of the internal tissue examined by the CW oximeters. For example, in the brain, the gray and white matter and the structures thereof are different in various individuals. In addition, the photon migration pathlength itself is a function of the relative concentration of absorbing constituents. As a result, the pathlength through an organ with a high blood hemoglobin concentration, for example, will be different from the same with a low blood hemoglobin concentration. Furthermore, the pathlength is frequently dependent upon the wavelength of the light since the absorption coefficient of many tissue constituents is wavelength dependent. Thus, where possible, it is advantageous to measure the pathlength directly when quantifying the hemoglobin concentration in tissue.
- In one aspect, the present invention is a pathlength corrected oximeter that utilizes principles of continuous wave spectroscopy and phase modulation spectroscopy. The oximeter is a compact unit constructed to be worn by a subject on the body over long periods of activity. The oximeter is also suitable for tissue monitoring in critical care facilities, in operating rooms while undergoing surgery or in trauma related situations.
- The oximeter is mounted on a body-conformable support structure placed on the skin. The support structure encapsulates several light emitting diodes (LEDs) generating light of different wavelengths introduced into the examined tissue and several photodiode detectors with interference filters for wavelength specific detection. Since both the LEDs and the photodiodes are placed directly on the skin, there is no need to use optical fibers. The distance between the LEDs and the diode detectors is selected to examine a targeted tissue region. The support structure also includes a conformable barrier, located between the LEDs and the diode detectors, designed to reduce detection of light that migrates subcutaneously from the source to the detector. The support structure may further include means for preventing escape of photons from the skin without being detected; the photon escape preventing means are located around the LEDs and the photodiode detectors.
- The LEDs, the diode detectors, and the electronic control circuitry of the oximeter are powered by a battery pack adapted to be worn on the body or by the standard 50/60 Hz supply. The electronic circuitry includes a processor for directing operation of the sources, the detectors and for directing the data acquisition and processing. The data may be displayed on a readout device worn by the user, sent by telemetry to a remote location or accumulated in a memory for later use.
- The oximeter is adapted to measure the attenuation of light migrating from the source to the detector and also to determine the average migration pathlength. The migration pathlength and the intensity attenuation data are then used for direct quantitation of a tissue property.
- In another aspect, the invention is a spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, including
- an oscillator adapted to generate a carrier waveform of a selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port; a light source, operatively connected to the oscillator, adapted to generate light of a selected wavelength that is intensity modulated at the frequency and introduced to a subject at the input port; a photodiode detector adapted to detect, at the detection port, light of the selected wavelength that has migrated in the tissue of the subject between the input and detection ports; a phase detector, operatively connected to receive signals from the oscillator and the diode detector, adapted to measure a phase shift between the introduced and the detected light; and a processor adapted to calculate pathlength based on the phase shift, and determine a physiological property of the examined tissue based on the pathlength.
- In another aspect, the invention is a spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, including an oscillator adapted to generate a carrier waveform of a selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port; a light source, operatively connected to the oscillator, adapted to generate light of a selected wavelength that is intensity modulated at the frequency and introduced to a subject at the input port; a photodiode detector adapted to detect, at the detection port, light of the selected wavelength that has migrated in the tissue of the subject between the input and detection ports; a phase splitter adapted to produce, based on the carrier waveform, first and second reference phase signals of predefined substantially different phase; first and second double balanced mixers adapted to correlate the reference phase signals and signals of the detected radiation to produce therefrom a real output signal and an imaginary output signal, respectively; and a processor adapted to calculate, on the basis of the real output signal and the imaginary output signal, a phase shift between the introduced light and the detected light, and determine a physiological property of the examined tissue based on the phase shift.
- In another aspect, the invention is a spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, comprising a first oscillator adapted to generate a carrier waveform of a first selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port; a light source, operatively connected to the oscillator, adapted to generate light of a selected wavelength, intensity modulated at the first frequency, that is introduced to a subject at the input port; a photodiode detector adapted to detect, at the detection port, light of the wavelength that has migrated in the tissue of the subject between the input and detection ports, the detector producing a detection signal at the first frequency corresponding to the detected light; a second oscillator adapted to generate a carrier waveform of a second frequency that is offset on the order of 104 Hz from the first frequency; a reference mixer, connected to the first and second oscillators, adapted to generate a reference signal of a frequency approximately equal to the difference between the first and second frequencies; a mixer connected to receive signals from the second oscillator and the detection signal and adapted to convert the detection signal to the difference frequency; a phase detector, operatively connected to receive signals from the reference mixer and the converted detection signal, adapted to measure a phase shift between the introduced light and the detected light; and a processor adapted to calculate the pathlength based on the phase shift, and to determine a physiological property of the examined tissue based on the pathlength.
- Preferred embodiments of these aspects may include one or more of the following features.
- The spectrophotometer may further include a magnitude detector, connected to the photodiode detector, adapted to measure magnitude of the detected light, and the processor is further adapted to receive the magnitude for determination of the physiological property.
- The spectrophotometer may further include a low frequency oximeter circuit, switchably connected to the source and the photodiode, adapted to determine absorption of light at the wavelength; and the processor is further adapted to receive absorption values from the oximeter circuit for determination of the physiological property.
- The spectrophotometer may further include two automatic gain controls adapted to level signals corresponding to the introduced light and the detected light, both the leveled signals being introduced to the phase detector.
- The photodiode detector may further include a substantially single wavelength filter.
- The spectrophotometer may further include a second light source, operatively connected to the oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a second input port; the photodiode detector further adapted to detect alternately, at the detection port, light of the first and second wavelengths that have migrated in the tissue of the subject between the first and the second input ports and the detection port, respectively; the phase detector further adapted to receive alternately signals corresponding to the detected first and second wavelengths; and the processor further adapted to receive alternately phase shifts from the phase detector, the phase shifts being subsequently used for determination of the physiological property of the tissue.
- The spectrophotometer may further include a second light source, operatively connected to the oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a second input port; a second photodiode detector adapted to detect, at a second detection port, light of the second wavelength that has migrated in the tissue of the subject between the second input port and the second detection port, respectively; a second phase detector, operatively connected to receive a reference signal and a detection signal from the third diode detector, adapted to measure a phase shift between the introduced and the detected light at the second wavelength; and the processor further adapted to receive a second phase shift at the second wavelength, the first and second phase shifts being subsequently used for determination of the physiological property of the tissue.
- The two wavelength spectrophotometer may further include a third light source, operatively connected to the oscillator, adapted to generate light of a third selected wavelength that is intensity modulated at the first frequency, the radiation being introduced to a subject at a third input port; a third photodiode detector adapted to detect, at a third detection port, light of the third wavelength that has migrated in the tissue of the subject between the third input port and the third detection port, respectively; a third phase detector, operatively connected to receive a reference signal and a detection signal from the third diode detector, adapted to measure a phase shift between the introduced and the detected light at the third wavelength; and the processor further adapted to receive phase shifts from the phase detector, the first second and third phase shifts being subsequently used for determination of the physiological property of the tissue.
- The two or three wavelength spectrophotometer may further include a first, a second (or a third) magnitude detector connected to the first, second (or third) photodiode detectors, respectively, the magnitude detectors being adapted to measure magnitude of the detected light at each of the wavelengths; and the processor further adapted to receive the magnitudes for determination of the physiological property of the tissue.
- The light source may be a light emitting diode for generating light of a selected wavelength in the visible or infra-red range.
- The photodiode detector may be a PIN diode or an avalanche diode.
- The examined physiological property of the tissue may be hemoglobin oxygenation, myoglobin, cytochrome iron and copper, melanin, glucose or other.
- FIG. 1 is a block diagram of a pathlength corrected oximeter in accordance with the present invention.
- FIG. 2 is a schematic circuit diagram of a 50.1 MHz (50.125 MHz) oscillator used in the oximeter of FIG. 1.
- FIG. 3 is a schematic circuit diagram of a PIN diode and a preamplifier used in the oximeter of FIG. 1.
- FIG. 4 is a schematic circuit diagram of a magnitude detector used in the oximeter of FIG. 1.
- FIG. 5 is a schematic circuit diagram of a 25 kHz filter used in the oximeter of FIG. 1.
- FIG. 6 is a schematic diagram of an AGC circuit of the oximeter of FIG. 1.
- FIG. 7 is a schematic circuit diagram of a phase detector of the oximeter of FIG. 1.
- FIG. 8A is a plan view of a source-detector probe of the oximeter.
- FIG. 8B is a transverse cross-sectional view taken on
lines 8B of FIG. 8A further showing the photon migration. - One preferred embodiment of the pathlength corrected oximeter utilizes three LEDs for generation of light at three selected wavelengths intensity modulated at a frequency of 50.1 MHz and coupled directly to the examined tissue. At each wavelength, the introduced light is altered by the tissue and is detected by a wide area photodiode placed against the skin. The introduced and detected radiations are compared to determine their relative phase shift that corresponds to an average pathlength of the migrating photons and, furthermore, the light attenuation is determined.
- Referring to FIG. 1, the oximeter includes a
master oscillator 10 operating at 50.1 MHz connected to apower amplifier 15 of sufficient output power to driveLEDs local oscillator 14 operating at 50.125 MHz andmixer 12 are used to generate areference frequency 13 of 25 kHz. Each LED directly positioned on the skin has an appropriate heat sink to eliminate uncomfortable temperature increases that could also alter blood perfusion of the surrounding tissue. ThreePIN diode detectors PIN diodes preamplifiers - The amplified signals (32 a, 32 b, 32 c) are sent to
magnitude detectors mixers local oscillator 14, converts the detection signal to a 25 kHz frequency signal (42 a, 42 b, 42 c). The mixers are high dynamic range frequency mixers, model SRA-1H, commercially available from Mini-Circuits (Brooklyn N.Y.). The detection signals (42 a, 42 b, and 42 c) are filtered byfilters -
Phase detectors Phase detectors processor 70. - FIG. 2 shows a schematic circuit diagram of a precision oscillator used as the 50.1
MHz master oscillator 10 and 50.125 MHzlocal oscillator 14. The oscillator crystals are neutralized for operation in the fundamental resonance mode; this achieves long-term stability. Both oscillators are thermally coupled so that their frequency difference is maintained constant at 25 kHz if a frequency drift occurs. -
PIN diodes respective preamplifiers stages voltage regulator 33. The amplified detection signals (32 a, 32 b, and 32 c) are sent tomagnitude detectors processor 70 that calculates the light attenuation ratio or logarithm thereof as shown Eq. 1. - Also referring to FIG. 5, the AGC circuit uses MC 1350 integrated circuit for amplification that maintains the input signal of phase detector60 at substantially constant levels. The amount of gain is selected to be equal for AGCs, 50 and 52. The signal amplitude is controlled by a
feedback network 53. The AGCs provide a substantially constant amplitude of the detected and reference signals to eliminate variations in the detected phase shift due to cross talk between amplitude and phase changes in the phase detector. - Referring to FIG. 6, each phase detector includes a Schmitt trigger that converts the substantially sinusoidal detection signal (54 a, 54 b, 54 c) and reference signal (56 a, 56 b, 56 c) to square waves. The square waves are input to a detector that has complementary MOS silicon-gate transistors. The phase shift signal is sent to
processor 70. - The oximeter is calibrated by measuring the phase shift for a selected distance in a known medium, i.e., using a standard delay unit, and by switching the length of a connector wire to change the electrical delay between
master oscillator 10 andlocal oscillator 14. - Referring to FIGS. 8A and 8B source-
detector probe 20 includes several LEDs (22 a, 22 b, 22 c) of selected wavelengths and PIN photodiodes (24 a, 24 b, 24 c) mounted in a body-conformable support structure 21.Structure 21 also includes aphoton escape barrier 27 made of a material with selected scattering and absorption properties (for example, styrofoam) designed to return escaping photons back to the examined tissue. The support structure further includes a secondconformable barrier 28, located between the LEDs and the diode detectors, designed to absorb photons directly propagating from the source to the detector and thus prevent detection of photons that migrate subcutaneously.Support structure 21 also includeselectronic circuitry 29 encapsulated by anelectronic shield 21 a. - Each PIN diode is provided with an evaporated single wavelength film filter (25 a, 25 b, 25 c). The filters eliminate the cross talk of different wavelength signals and allow continuous operation of the three light sources, i.e., no time sharing is needed.
- The use of photodiode detectors has substantial advantages when compared with the photomultiplier tube used in standard phase modulation systems. The photodiodes are placed directly on the skin, i.e., no optical fibers are needed. Furthermore, there is no need to use a high voltage power supply that is necessary for the photomultiplier tube. The photodiodes are much smaller and are easy to place close to the skin. Advantages of the photomultiplier tube are a huge multiplication gain and a possibility of direct mixing at the photomultiplier; this cannot be achieved directly by a photodiode. This invention envisions the use of several different photodiodes such as PIN diode, avalanche diode, and other.
- The processor uses algorithms that are based on equations described by E. M. Sevick et al. in “Quantitation of Time- and Frequency-Resolved Optical Spectra for the Determination of Tissue Oxygenation” published in Analytical Biochemistry 195, 330 Apr. 15, 1991 which is incorporated by reference as if fully set forth herein.
-
- wherein f is modulation frequency of the introduced light which is in the range of 10 MHz to 100 MHz; tλ is the photon migration delay time; c is the speed of photons in the scattering medium; and Lλ is the migration pathlength.
-
-
- wherein θ0 λ represents background scattering and absorption.
- The wavelengths are in the visible and infra-red range and are selected to have absorbance sensitive (or insensitive) to various tissue components such as water, cytochrome iron and copper, oxy- and deoxygenated forms of hemoglobin, myoglobin, melanin, glucose and other.
-
-
-
- Thus,
processor 70 determines Y based on Eq. (7) using Eq. (2) to determine the average migration pathlength L that is then used in Eq. (1) and to determine μa λ for each wavelength λ1, λ2, λ3. - In another embodiment, the spectrophotometer's electronics includes a low frequency module suitably and a high frequency module switchably coupled to the same source-
detector probe 20. The low frequency module and the arrangement of the source-detector probe are substantially similar to the hemoglobinometer described in a copending U.S. patent application Ser. No. 701,127 filed May 16, 1991 which is incorporated by reference as if fully set forth herein. The low frequency module corresponds to a standard oximeter with modulation frequencies in the range of a few hertz to 104 hertz and is adapted to provide intensity attenuation data at two or three wavelengths. Then, the LEDs are switched to the high frequency phase modulation unit, similar to the unit of FIG. 1, which determines the average pathlength at each wavelength. The attenuation and pathlength data are sent toprocessor 70 for determination of a physiological property of the examined tissue. -
- The amplitude is the square root of the sum of the squares of these values, providing the phase shift has been taken out as the residual phase shift θ set to zero.
- A λ={square root}{square root over ((R λ)2+(I λ)2)} (9)
-
- The phase processor receives the phase shifts for the phase and amplitude values for two or three wavelengths and calculates the ratio of the phase shifts.
- For each wavelength, the phase shift and the DC amplitude are used to determine a selected tissue property, e.g., hemoglobin oxygenation.
- Additional embodiments are within the following claims:
Claims (21)
1. A spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, comprising:
an oscillator adapted to generate a carrier waveform of a selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port;
a light source, operatively connected to said oscillator, adapted to generate light of a selected wavelength that is intensity modulated at said frequency, said light being introduced to a subject at said input port;
a photodiode detector adapted to detect, at said detection port, light of said wavelength that has migrated in said tissue of the subject between said input and detection ports;
a phase detector, operatively connected to receive signals from said oscillator and said diode detector, adapted to measure a phase shift between said introduced and said detected light;
a processor adapted to determine said pathlength based on said phase shift; and
said processor further adapted to determine a physiological property of the examined tissue based on said pathlength.
2. A spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, comprising:
an oscillator adapted to generate a carrier waveform of a selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port;
a light source, operatively connected to said oscillator, adapted to generate light of a selected wavelength that is intensity modulated at said frequency, said light being introduced to a subject at said input port;
a photodiode detector adapted to detect, at said detection port, light of said wavelength that has migrated in said tissue of the subject between said input and detection ports;
a phase splitter adapted to produce, based on said carrier waveform, first and second reference phase signals of predefined substantially different phase;
first and second double balanced mixers adapted to correlate said reference phase signals and signals of said detected radiation to produce therefrom a real output signal and an imaginary output signal, respectively;
a processor adapted to determine, on the basis of said real output signal and said imaginary output signal, a phase shift between said introduced light and said detected light; and
said processor further adapted to determine a physiological property of the examined tissue based on said phase shift.
3. A spectrophotometer for tissue examination utilizing a measured average pathlength of migrating photons, comprising:
a first oscillator adapted to generate a carrier waveform of a first selected frequency comparable to an average migration time of photons scattered in tissue on paths from an optical input port to an optical detection port;
a light source, operatively connected to said oscillator, adapted to generate light of a selected wavelength that is intensity modulated at said first frequency, said light being introduced to a subject at said input port;
a photodiode detector adapted to detect, at said detection port, light of said wavelength that has migrated in said tissue of the subject between said input and detection ports, said detector producing a detection signal at said first frequency corresponding to said detected light;
a second oscillator adapted to generate a carrier waveform of a second frequency that is offset on the order of 104 Hz from said first frequency;
a reference mixer, connected to said first and second oscillators, adapted to generate a reference signal of a frequency approximately equal to the difference between said first and second frequencies;
a mixer connected to receive signals from said second oscillator and said detection signal and adapted to convert said detection signal to said difference frequency;
a phase detector, operatively connected to receive signals from said reference mixer and said converted detection signal, adapted to measure a phase shift between said introduced light and said detected light,
a processor adapted to determine said pathlength based on said phase shift; and
said processor further adapted to determine a physiological property of the examined tissue based on said pathlength.
4. The spectrophotometer of claims 1, 2 or 3 further comprising:
a magnitude detector, connected to said photodiode detector, adapted to measure magnitude of said detected light, and
said processor further adapted to receive said magnitude for determination of said physiological property.
5. The spectrophotometer of claims 1, 2 or 3 further comprising:
a low frequency oximeter circuit, switchably connected to said source and said photodiode, adapted to determine absorption of light at said wavelength; and
said processor further adapted to receive absorption values from said oximeter circuit for determination of said physiological property.
6. The spectrophotometer of claims 1 or 3 further comprising two automatic gain controls adapted to level signals corresponding to said introduced light and said detected light, both said leveled signals being introduced to said phase detector.
7. The spectrophotometer of claims 1 or 3 further comprising:
a magnitude detector, connected to said photodiode detector, adapted to measure magnitude of said detected light, and
two automatic gain controls adapted to level signals corresponding to said introduced light and said detected light, both said leveled signals being introduced to said phase detector.
8. The spectrophotometer of claims 1, 2 or 3 wherein said light source is a light emitting diode and said selected wavelength is in the visible or infra-red range.
9. The spectrophotometer of claims 1, 2 or 3 wherein said photodiode detector is a PIN diode.
10. The spectrophotometer of claims 1, 2 or 3 wherein said photodiode detector is an avalanche diode.
11. The spectrophotometer of claims 1, 2 or 3 wherein said photodiode detector further comprises a substantially single wavelength filter.
12. The spectrophotometer of claims 1, 2 or 3 further comprising:
a second light source, operatively connected to said oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at said first frequency, said radiation being introduced to a subject at a second input port;
said photodiode detector further adapted to detect alternately, at said detection port, light of said first and second wavelengths that have migrated in said tissue of the subject between the first and said second input ports and said detection port, respectively;
said phase detector further adapted to receive alternately signals corresponding to said detected first and second wavelengths; and
said processor further adapted to receive alternately phase shifts from said phase detector, said phase shifts being subsequently used for determination of said physiological property.
13. The spectrophotometer of claim 12 further comprising:
a magnitude detector, connected to said photodiode detector, adapted to measure magnitude of said detected light at each of said wavelengths, and
said processor further adapted to receive said magnitudes for determination of said physiological property.
14. The spectrophotometer of claims 1 or 3 further comprising:
a second light source, operatively connected to said oscillator, adapted to generate light of a second selected wavelength that is intensity modulated at said first frequency, said radiation being introduced to a subject at a second input port;
a second photodiode detector adapted to detect, at a second detection port, light of said second wavelength that has migrated in said tissue of the subject between said second input port and said second detection port, respectively;
a second phase detector, operatively connected to receive a reference signal and a detection signal from said third diode detector, adapted to measure a phase shift between said introduced and said detected light at said second wavelength; and
said processor further adapted to receive a second phase shift at said second wavelength, said first and second phase shifts being subsequently used for determination of said physiological property.
15. The spectrophotometer of claim 14 further comprising:
a first and a second magnitude detector connected to said first and second photodiode detectors, respectively, said magnitude detectors being adapted to measure magnitude of said detected light at each of said wavelengths, and
said processor further adapted to receive said magnitudes for determination of said physiological property.
16. The spectrophotometer of claims 14 further comprising:
a third light source, operatively connected to said oscillator, adapted to generate light of a third selected wavelength that is intensity modulated at said first frequency, said radiation being introduced to a subject at a third input port;
a third photodiode detector adapted to detect, at a third detection port, light of said third wavelength that has migrated in said tissue of the subject between said third input port and said third detection port, respectively;
a third phase detector, operatively connected to receive a reference signal and a detection signal from said third diode detector, adapted to measure a phase shift between said introduced and said detected light at said third wavelength; and
said processor further adapted to receive phase shifts from said phase detector, said first second and third phase shifts being subsequently used for determination of said physiological property.
17. The spectrophotometer of claim 14 further comprising:
a first, a second and a third magnitude detector connected to said first, second and third photodiode detectors, respectively, said magnitude detectors being adapted to measure magnitude of said detected light at each of said wavelengths; and
said processor further adapted to receive said magnitudes for determination of said physiological property.
18. The spectrophotometer of claim 16 wherein each said light source is a light emitting diode and said selected wavelength is in the visible or infra-red range.
19. The spectrophotometer of claim 16 wherein each said photodiode detector is a PIN diode.
20. The spectrophotometer of claim 16 wherein each said photodiode detector is an avalanche diode.
21. The spectrophotometer of claim 16 wherein each said photodiode detector further comprises a substantially single wavelength filter.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/174,482 US20030023140A1 (en) | 1989-02-06 | 2002-06-18 | Pathlength corrected oximeter and the like |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/307,066 US4972331A (en) | 1989-02-06 | 1989-02-06 | Phase modulated spectrophotometry |
US07/578,063 US5122974A (en) | 1989-02-06 | 1990-09-05 | Phase modulated spectrophotometry |
US64559091A | 1991-01-24 | 1991-01-24 | |
US08/031,945 US5564417A (en) | 1991-01-24 | 1993-03-16 | Pathlength corrected oximeter and the like |
US08/076,370 US5553614A (en) | 1988-12-21 | 1993-06-14 | Examination of biological tissue using frequency domain spectroscopy |
US08/731,443 US6134460A (en) | 1988-11-02 | 1996-10-15 | Spectrophotometers with catheters for measuring internal tissue |
US09/299,284 US6183414B1 (en) | 1999-04-26 | 1999-04-26 | Technique for restoring plasticity to tissues of a male or female organ |
US10/174,482 US20030023140A1 (en) | 1989-02-06 | 2002-06-18 | Pathlength corrected oximeter and the like |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/299,284 Continuation US6183414B1 (en) | 1989-02-06 | 1999-04-26 | Technique for restoring plasticity to tissues of a male or female organ |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030023140A1 true US20030023140A1 (en) | 2003-01-30 |
Family
ID=23154125
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/299,284 Expired - Lifetime US6183414B1 (en) | 1989-02-06 | 1999-04-26 | Technique for restoring plasticity to tissues of a male or female organ |
US10/174,482 Abandoned US20030023140A1 (en) | 1989-02-06 | 2002-06-18 | Pathlength corrected oximeter and the like |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/299,284 Expired - Lifetime US6183414B1 (en) | 1989-02-06 | 1999-04-26 | Technique for restoring plasticity to tissues of a male or female organ |
Country Status (1)
Country | Link |
---|---|
US (2) | US6183414B1 (en) |
Cited By (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040221370A1 (en) * | 2002-10-01 | 2004-11-11 | Nellcor Puritan Bennett Incorporated | Headband with tension indicator |
US20050197579A1 (en) * | 2004-03-08 | 2005-09-08 | Nellcor Puritan Bennett Incorporated | Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue |
US20060030764A1 (en) * | 1999-04-14 | 2006-02-09 | Mallinckrodt Inc. | Method and circuit for indicating quality and accuracy of physiological measurements |
US20060135860A1 (en) * | 2003-01-10 | 2006-06-22 | Baker Clark R Jr | Signal quality metrics design for qualifying data for a physiological monitor |
US20060195041A1 (en) * | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US20060195028A1 (en) * | 2003-06-25 | 2006-08-31 | Don Hannula | Hat-based oximeter sensor |
US20070032714A1 (en) * | 2001-07-19 | 2007-02-08 | Nellcor Puritan Bennett Inc. | Nuisance alarm reductions in a physiological monitor |
US20070073124A1 (en) * | 2005-09-29 | 2007-03-29 | Li Li | System and method for removing artifacts from waveforms |
US20070093721A1 (en) * | 2001-05-17 | 2007-04-26 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
US20070106137A1 (en) * | 2004-03-09 | 2007-05-10 | Baker Clark R Jr | Pulse oximetry signal correction using near infrared absorption by water |
US20070129647A1 (en) * | 2000-07-28 | 2007-06-07 | Lynn Lawrence A | System and method for CO2 and oximetry integration |
US20080076977A1 (en) * | 2006-09-26 | 2008-03-27 | Nellcor Puritan Bennett Inc. | Patient monitoring device snapshot feature system and method |
US20080076986A1 (en) * | 2006-09-20 | 2008-03-27 | Nellcor Puritan Bennett Inc. | System and method for probability based determination of estimated oxygen saturation |
US20080081956A1 (en) * | 2006-09-29 | 2008-04-03 | Jayesh Shah | System and method for integrating voice with a medical device |
US20080081970A1 (en) * | 2006-09-29 | 2008-04-03 | Nellcor Puritan Bennett Incorporated | Pulse oximetry sensor switchover |
US20080082338A1 (en) * | 2006-09-29 | 2008-04-03 | O'neil Michael P | Systems and methods for secure voice identification and medical device interface |
US20080081974A1 (en) * | 2006-09-29 | 2008-04-03 | Nellcor Puritan Bennett Incorporated | Pathological condition detector using kernel methods and oximeters |
US20080082339A1 (en) * | 2006-09-29 | 2008-04-03 | Nellcor Puritan Bennett Incorporated | System and method for secure voice identification in a medical device |
US20080097175A1 (en) * | 2006-09-29 | 2008-04-24 | Boyce Robin S | System and method for display control of patient monitor |
US20080114226A1 (en) * | 2006-09-29 | 2008-05-15 | Doug Music | Systems and methods for user interface and identification in a medical device |
US20080114211A1 (en) * | 2006-09-29 | 2008-05-15 | Edward Karst | System and method for assuring validity of monitoring parameter in combination with a therapeutic device |
US20080189783A1 (en) * | 2006-09-29 | 2008-08-07 | Doug Music | User interface and identification in a medical device system and method |
US20080200775A1 (en) * | 2007-02-20 | 2008-08-21 | Lynn Lawrence A | Maneuver-based plethysmographic pulse variation detection system and method |
US20080200819A1 (en) * | 2007-02-20 | 2008-08-21 | Lynn Lawrence A | Orthostasis detection system and method |
US20080214906A1 (en) * | 2006-03-21 | 2008-09-04 | Nellcor Puritan Bennett Llc | Patient Monitoring Help Video System and Method |
US20080221426A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | Methods and apparatus for detecting misapplied optical sensors |
US20080221427A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US20080255436A1 (en) * | 2005-03-03 | 2008-10-16 | Nellcor Puritain Bennett Incorporated | Method for Enhancing Pulse Oximery Calculations in the Presence of Correlated Artifacts |
US20090005662A1 (en) * | 2004-02-25 | 2009-01-01 | Nellcor Puritan Bennett Inc | Oximeter Ambient Light Cancellation |
US20090082651A1 (en) * | 2004-03-08 | 2009-03-26 | Nellcor Puritan Bennett Llc | Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics |
US20090080007A1 (en) * | 2007-09-25 | 2009-03-26 | Brother Kogyo Kabushiki Kaisha | Printing device and method therefor |
US20090154573A1 (en) * | 2007-12-13 | 2009-06-18 | Nellcor Puritan Bennett Llc | Signal Demodulation |
US20090171173A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for reducing motion artifacts in a sensor |
US20090171172A1 (en) * | 2008-12-19 | 2009-07-02 | Nellcor Puritan Bennett Llc | Method and system for pulse gating |
US20090171167A1 (en) * | 2007-12-27 | 2009-07-02 | Nellcor Puritan Bennett Llc | System And Method For Monitor Alarm Management |
US20090171226A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for evaluating variation in the timing of physiological events |
US20090171166A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | Oximeter with location awareness |
US20090171174A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for maintaining battery life |
US20090209839A1 (en) * | 2008-02-19 | 2009-08-20 | Nellcor Puritan Bennett Llc | Methods And Systems For Alerting Practitioners To Physiological Conditions |
US20090210163A1 (en) * | 2008-02-19 | 2009-08-20 | Nellcor Puritan Bennett Llc | System And Method For Evaluating Physiological Parameter Data |
US20090247850A1 (en) * | 2008-03-28 | 2009-10-01 | Nellcor Puritan Bennett Llc | Manually Powered Oximeter |
US20090247852A1 (en) * | 2008-03-31 | 2009-10-01 | Nellcor Puritan Bennett Llc | System and method for facilitating sensor and monitor communication |
US20090247851A1 (en) * | 2008-03-26 | 2009-10-01 | Nellcor Puritan Bennett Llc | Graphical User Interface For Monitor Alarm Management |
US20090247845A1 (en) * | 2008-03-28 | 2009-10-01 | Nellcor Puritan Bennett Llc | System And Method For Estimating Blood Analyte Concentration |
US20090247083A1 (en) * | 2008-03-31 | 2009-10-01 | Nellcor Puritan Bennett Llc | Wavelength Selection And Outlier Detection In Reduced Rank Linear Models |
US20090248320A1 (en) * | 2008-03-27 | 2009-10-01 | Nellcor Puritan Benett Llc | System And Method For Unmixing Spectroscopic Observations With Nonnegative Matrix Factorization |
US20090247854A1 (en) * | 2008-03-27 | 2009-10-01 | Nellcor Puritan Bennett Llc | Retractable Sensor Cable For A Pulse Oximeter |
US20090253971A1 (en) * | 2005-10-28 | 2009-10-08 | Nellcor Puritan Bennett Llc | Adjusting parameters used in pulse oximetry analysis |
US20090281838A1 (en) * | 2008-05-07 | 2009-11-12 | Lawrence A. Lynn | Medical failure pattern search engine |
US20090326335A1 (en) * | 2008-06-30 | 2009-12-31 | Baker Clark R | Pulse Oximeter With Wait-Time Indication |
US20090327515A1 (en) * | 2008-06-30 | 2009-12-31 | Thomas Price | Medical Monitor With Network Connectivity |
US20100076319A1 (en) * | 2008-09-25 | 2010-03-25 | Nellcor Puritan Bennett Llc | Pathlength-Corrected Medical Spectroscopy |
US20100076337A1 (en) * | 2008-09-25 | 2010-03-25 | Nellcor Puritan Bennett Llc | Medical Sensor And Technique For Using The Same |
US20100081897A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | Transmission Mode Photon Density Wave System And Method |
US20100081899A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | System and Method for Photon Density Wave Pulse Oximetry and Pulse Hemometry |
US20100081890A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | System And Method For Enabling A Research Mode On Physiological Monitors |
US20100079292A1 (en) * | 1997-01-27 | 2010-04-01 | Lawrence A. Lynn | Microprocessor system for the analysis of physiologic and financial datasets |
US20100113908A1 (en) * | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System And Method For Facilitating Observation Of Monitored Physiologic Data |
US20100113909A1 (en) * | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System And Method For Facilitating Observation Of Monitored Physiologic Data |
US7720516B2 (en) | 1996-10-10 | 2010-05-18 | Nellcor Puritan Bennett Llc | Motion compatible sensor for non-invasive optical blood analysis |
US7725146B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for pre-processing waveforms |
US20100174161A1 (en) * | 2006-02-10 | 2010-07-08 | Lynn Lawrence A | System and method for the detection of physiologic response to stimulation |
US20100240972A1 (en) * | 2009-03-20 | 2010-09-23 | Nellcor Puritan Bennett Llc | Slider Spot Check Pulse Oximeter |
US7822453B2 (en) | 2002-10-01 | 2010-10-26 | Nellcor Puritan Bennett Llc | Forehead sensor placement |
USD626562S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Triangular saturation pattern detection indicator for a patient monitor display panel |
USD626561S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Circular satseconds indicator and triangular saturation pattern detection indicator for a patient monitor display panel |
US7848891B2 (en) | 2006-09-29 | 2010-12-07 | Nellcor Puritan Bennett Llc | Modulation ratio determination with accommodation of uncertainty |
US20110029865A1 (en) * | 2009-07-31 | 2011-02-03 | Nellcor Puritan Bennett Llc | Control Interface For A Medical Monitor |
US20110071366A1 (en) * | 2009-09-24 | 2011-03-24 | Nellcor Puritan Bennett Llc | Determination Of A Physiological Parameter |
US20110071373A1 (en) * | 2009-09-21 | 2011-03-24 | Nellcor Puritan Bennett Llc | Time-Division Multiplexing In A Multi-Wavelength Photon Density Wave System |
US20110071376A1 (en) * | 2009-09-24 | 2011-03-24 | Nellcor Puritan Bennett Llc | Determination Of A Physiological Parameter |
US20110071368A1 (en) * | 2009-09-21 | 2011-03-24 | Nellcor Puritan Bennett Llc | Medical Device Interface Customization Systems And Methods |
US20110071598A1 (en) * | 2009-09-24 | 2011-03-24 | Nellcor Puritan Bennett Llc | Photoacoustic Spectroscopy Method And System To Discern Sepsis From Shock |
US20110071371A1 (en) * | 2009-09-21 | 2011-03-24 | Nellcor Puritan Bennett Llc | Wavelength-Division Multiplexing In A Multi-Wavelength Photon Density Wave System |
US20110077470A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Patient Monitor Symmetry Control |
US20110077485A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Method Of Analyzing Photon Density Waves In A Medical Monitor |
US20110074342A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Wireless electricity for electronic devices |
US20110077547A1 (en) * | 2009-09-29 | 2011-03-31 | Nellcor Puritan Bennett Llc | Spectroscopic Method And System For Assessing Tissue Temperature |
US7922665B2 (en) | 2006-09-28 | 2011-04-12 | Nellcor Puritan Bennett Llc | System and method for pulse rate calculation using a scheme for alternate weighting |
US8007441B2 (en) | 2004-03-08 | 2011-08-30 | Nellcor Puritan Bennett Llc | Pulse oximeter with alternate heart-rate determination |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US8195262B2 (en) | 2004-02-25 | 2012-06-05 | Nellcor Puritan Bennett Llc | Switch-mode oximeter LED drive with a single inductor |
US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
US8292809B2 (en) | 2008-03-31 | 2012-10-23 | Nellcor Puritan Bennett Llc | Detecting chemical components from spectroscopic observations |
US8364221B2 (en) | 2005-09-30 | 2013-01-29 | Covidien Lp | Patient monitoring alarm escalation system and method |
US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
US8380271B2 (en) | 2006-06-15 | 2013-02-19 | Covidien Lp | System and method for generating customizable audible beep tones and alarms |
US8391943B2 (en) | 2010-03-31 | 2013-03-05 | Covidien Lp | Multi-wavelength photon density wave system using an optical switch |
US8412297B2 (en) | 2003-10-01 | 2013-04-02 | Covidien Lp | Forehead sensor placement |
US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
US8494786B2 (en) | 2009-07-30 | 2013-07-23 | Covidien Lp | Exponential sampling of red and infrared signals |
US8494606B2 (en) | 2009-08-19 | 2013-07-23 | Covidien Lp | Photoplethysmography with controlled application of sensor pressure |
US8498683B2 (en) | 2010-04-30 | 2013-07-30 | Covidien LLP | Method for respiration rate and blood pressure alarm management |
US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
US8515511B2 (en) | 2009-09-29 | 2013-08-20 | Covidien Lp | Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same |
US8515515B2 (en) | 2009-03-25 | 2013-08-20 | Covidien Lp | Medical sensor with compressible light barrier and technique for using the same |
US8571621B2 (en) | 2009-09-24 | 2013-10-29 | Covidien Lp | Minimax filtering for pulse oximetry |
US8610769B2 (en) | 2011-02-28 | 2013-12-17 | Covidien Lp | Medical monitor data collection system and method |
US8666467B2 (en) | 2001-05-17 | 2014-03-04 | Lawrence A. Lynn | System and method for SPO2 instability detection and quantification |
US8696593B2 (en) | 2006-09-27 | 2014-04-15 | Covidien Lp | Method and system for monitoring intracranial pressure |
US8781548B2 (en) | 2009-03-31 | 2014-07-15 | Covidien Lp | Medical sensor with flexible components and technique for using the same |
CN104068865A (en) * | 2014-04-24 | 2014-10-01 | 辛勤 | Oxyhemoglobin saturation measuring method and portable device |
US8862194B2 (en) | 2008-06-30 | 2014-10-14 | Covidien Lp | Method for improved oxygen saturation estimation in the presence of noise |
US8930145B2 (en) | 2010-07-28 | 2015-01-06 | Covidien Lp | Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring |
US8983800B2 (en) | 2003-01-13 | 2015-03-17 | Covidien Lp | Selection of preset filter parameters based on signal quality |
US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
CN105286883A (en) * | 2015-09-11 | 2016-02-03 | 蚌埠医学院 | Pulse hemoglobin concentration non-invasive measurement method and device |
US9380982B2 (en) | 2010-07-28 | 2016-07-05 | Covidien Lp | Adaptive alarm system and method |
US9468378B2 (en) | 1997-01-27 | 2016-10-18 | Lawrence A. Lynn | Airway instability detection system and method |
US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US9585606B2 (en) | 2009-09-29 | 2017-03-07 | Covidien Lp | Oximetry assembly |
US20170143242A1 (en) * | 2008-05-22 | 2017-05-25 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US9833146B2 (en) | 2012-04-17 | 2017-12-05 | Covidien Lp | Surgical system and method of use of the same |
US10241033B2 (en) | 2010-03-05 | 2019-03-26 | Seiko Epson Corporation | Spectroscopic sensor device and electronic equipment |
US10542919B2 (en) | 2008-03-25 | 2020-01-28 | St. Louis Medical Devices, Inc. | Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8287474B1 (en) | 2002-08-22 | 2012-10-16 | Koenig J Frank | Method and apparatus for noninvasively increasing whole body blood flow and noninvasive physical exercise of limbs from the outside and from within the limb to treat diseases throughout the body |
US7037257B1 (en) * | 2002-08-22 | 2006-05-02 | Koenig J Frank | Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications |
US7037256B2 (en) * | 2002-10-16 | 2006-05-02 | Soma Blue, Inc. | Method, system and kit for treatment of Peyronie's disease |
US8137262B2 (en) * | 2002-10-16 | 2012-03-20 | Augusta Medical Systems, Inc. | Kit, system and method to treat erectile dysfunction |
US20050119521A1 (en) * | 2003-12-02 | 2005-06-02 | Pitcher Rex L. | Vacuum exercise device for promoting expansion of soft-tissue |
US7572220B2 (en) * | 2005-04-19 | 2009-08-11 | Nanma Manufacturing Co., Ltd. | Collapsible vacuum device |
US20070156014A1 (en) * | 2005-12-29 | 2007-07-05 | Nikos Zafirakis | Angled male member enlargement pump |
US8500626B2 (en) * | 2008-05-15 | 2013-08-06 | Alagin Research LLC | System and method for treating and/or preventing erection problems |
US20100130813A1 (en) * | 2008-11-24 | 2010-05-27 | Dmitri Dozortsev | Method and apparatus for attaining lucid dream state |
US20140142374A1 (en) | 2012-11-21 | 2014-05-22 | ExploraMed NC6, LLC | Devices and Methods for Promoting Female Sexual Wellness |
SE537386C2 (en) * | 2012-11-30 | 2015-04-14 | Nuelle Inc | Apparatus for promoting female sexual well-being |
CN107205881B (en) * | 2015-02-17 | 2021-05-28 | 株式会社典雅 | Pressure reducing device of ejaculation stimulating device |
US20170224522A1 (en) * | 2016-02-05 | 2017-08-10 | Global Health & Innovation | Vacuum therapy apparatus |
US10588817B2 (en) * | 2016-02-11 | 2020-03-17 | Kevin Joseph Dorsey | Vacuum-driven personal device |
US11154414B2 (en) * | 2018-05-15 | 2021-10-26 | Nugyn, Inc. | Apparatus and methods for treating venous occlusive disorders |
US11179267B2 (en) * | 2018-05-15 | 2021-11-23 | Nugyn, Inc. | Apparatus and methods for treating venous occlusive disorders |
CN112545738A (en) * | 2020-12-18 | 2021-03-26 | 上海乐斟电子科技有限公司 | Water-gas dual-purpose electric erection aid |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1225341A (en) * | 1913-11-29 | 1917-05-08 | Otto Lederer | Surgical device. |
US4378008A (en) * | 1981-05-15 | 1983-03-29 | Osbon Sr Geddings D | Erection aid device |
US4856498A (en) * | 1987-03-30 | 1989-08-15 | Osbon Medical Systems, Ltd. | Vacuum generating and constriction apparatus for augmenting male potency |
US5083556A (en) * | 1990-05-31 | 1992-01-28 | Osbon Medical Systems, Ltd. | Penile cincture band operational apparatus |
US5094230A (en) * | 1991-09-19 | 1992-03-10 | Clark Jr Buford E | Method and apparatus for treating Peyronie's disease |
US5195943A (en) * | 1991-09-30 | 1993-03-23 | Chaney John L | Male organ restrictor ring applicator |
US5421808A (en) * | 1993-07-30 | 1995-06-06 | Osbon Medical Systems, Ltd. | Battery-operated male organ conditioning appliance |
US5951460A (en) * | 1996-01-11 | 1999-09-14 | Vollrath; Andrew J. | Non-invasive penile erection device |
-
1999
- 1999-04-26 US US09/299,284 patent/US6183414B1/en not_active Expired - Lifetime
-
2002
- 2002-06-18 US US10/174,482 patent/US20030023140A1/en not_active Abandoned
Cited By (212)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7720516B2 (en) | 1996-10-10 | 2010-05-18 | Nellcor Puritan Bennett Llc | Motion compatible sensor for non-invasive optical blood analysis |
US9468378B2 (en) | 1997-01-27 | 2016-10-18 | Lawrence A. Lynn | Airway instability detection system and method |
US20100079292A1 (en) * | 1997-01-27 | 2010-04-01 | Lawrence A. Lynn | Microprocessor system for the analysis of physiologic and financial datasets |
US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US20100234705A1 (en) * | 1997-01-27 | 2010-09-16 | Lynn Lawrence A | System and Method for Automatic Detection of a Plurality of SP02 Time Series Pattern Types |
US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US8133176B2 (en) | 1999-04-14 | 2012-03-13 | Tyco Healthcare Group Lp | Method and circuit for indicating quality and accuracy of physiological measurements |
US20060030764A1 (en) * | 1999-04-14 | 2006-02-09 | Mallinckrodt Inc. | Method and circuit for indicating quality and accuracy of physiological measurements |
US10058269B2 (en) | 2000-07-28 | 2018-08-28 | Lawrence A. Lynn | Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility |
US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
US20070129647A1 (en) * | 2000-07-28 | 2007-06-07 | Lynn Lawrence A | System and method for CO2 and oximetry integration |
US8666467B2 (en) | 2001-05-17 | 2014-03-04 | Lawrence A. Lynn | System and method for SPO2 instability detection and quantification |
US20070093721A1 (en) * | 2001-05-17 | 2007-04-26 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
US8862196B2 (en) | 2001-05-17 | 2014-10-14 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SP02 time series pattern types |
US11439321B2 (en) | 2001-05-17 | 2022-09-13 | Lawrence A. Lynn | Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility |
US10366790B2 (en) | 2001-05-17 | 2019-07-30 | Lawrence A. Lynn | Patient safety processor |
US10354753B2 (en) | 2001-05-17 | 2019-07-16 | Lawrence A. Lynn | Medical failure pattern search engine |
US10297348B2 (en) | 2001-05-17 | 2019-05-21 | Lawrence A. Lynn | Patient safety processor |
US10032526B2 (en) | 2001-05-17 | 2018-07-24 | Lawrence A. Lynn | Patient safety processor |
US9031793B2 (en) | 2001-05-17 | 2015-05-12 | Lawrence A. Lynn | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US20070032714A1 (en) * | 2001-07-19 | 2007-02-08 | Nellcor Puritan Bennett Inc. | Nuisance alarm reductions in a physiological monitor |
US8838196B2 (en) | 2001-07-19 | 2014-09-16 | Covidien Lp | Nuisance alarm reductions in a physiological monitor |
US8401606B2 (en) | 2001-07-19 | 2013-03-19 | Covidien Lp | Nuisance alarm reductions in a physiological monitor |
US8401607B2 (en) | 2001-07-19 | 2013-03-19 | Covidien Lp | Nuisance alarm reductions in a physiological monitor |
US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
US20060195041A1 (en) * | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US7698909B2 (en) | 2002-10-01 | 2010-04-20 | Nellcor Puritan Bennett Llc | Headband with tension indicator |
US20110009723A1 (en) * | 2002-10-01 | 2011-01-13 | Nellcor Puritan Bennett Llc | Forehead sensor placement |
US7822453B2 (en) | 2002-10-01 | 2010-10-26 | Nellcor Puritan Bennett Llc | Forehead sensor placement |
US8452367B2 (en) | 2002-10-01 | 2013-05-28 | Covidien Lp | Forehead sensor placement |
US7899509B2 (en) | 2002-10-01 | 2011-03-01 | Nellcor Puritan Bennett Llc | Forehead sensor placement |
US20040221370A1 (en) * | 2002-10-01 | 2004-11-11 | Nellcor Puritan Bennett Incorporated | Headband with tension indicator |
US8095192B2 (en) | 2003-01-10 | 2012-01-10 | Nellcor Puritan Bennett Llc | Signal quality metrics design for qualifying data for a physiological monitor |
US20060135860A1 (en) * | 2003-01-10 | 2006-06-22 | Baker Clark R Jr | Signal quality metrics design for qualifying data for a physiological monitor |
US8983800B2 (en) | 2003-01-13 | 2015-03-17 | Covidien Lp | Selection of preset filter parameters based on signal quality |
US7877126B2 (en) | 2003-06-25 | 2011-01-25 | Nellcor Puritan Bennett Llc | Hat-based oximeter sensor |
US7979102B2 (en) | 2003-06-25 | 2011-07-12 | Nellcor Puritan Bennett Llc | Hat-based oximeter sensor |
US20060264722A1 (en) * | 2003-06-25 | 2006-11-23 | Don Hannula | Hat-based oximeter sensor |
US20060264724A1 (en) * | 2003-06-25 | 2006-11-23 | Don Hannula | Hat-based oximeter sensor |
US20060195028A1 (en) * | 2003-06-25 | 2006-08-31 | Don Hannula | Hat-based oximeter sensor |
US20060264725A1 (en) * | 2003-06-25 | 2006-11-23 | Don Hannula | Hat-based oximeter sensor |
US7809420B2 (en) | 2003-06-25 | 2010-10-05 | Nellcor Puritan Bennett Llc | Hat-based oximeter sensor |
US7877127B2 (en) | 2003-06-25 | 2011-01-25 | Nellcor Puritan Bennett Llc | Hat-based oximeter sensor |
US7813779B2 (en) | 2003-06-25 | 2010-10-12 | Nellcor Puritan Bennett Llc | Hat-based oximeter sensor |
US8412297B2 (en) | 2003-10-01 | 2013-04-02 | Covidien Lp | Forehead sensor placement |
US8195262B2 (en) | 2004-02-25 | 2012-06-05 | Nellcor Puritan Bennett Llc | Switch-mode oximeter LED drive with a single inductor |
US8874181B2 (en) | 2004-02-25 | 2014-10-28 | Covidien Lp | Oximeter ambient light cancellation |
US8315684B2 (en) | 2004-02-25 | 2012-11-20 | Covidien Lp | Oximeter ambient light cancellation |
US20090005662A1 (en) * | 2004-02-25 | 2009-01-01 | Nellcor Puritan Bennett Inc | Oximeter Ambient Light Cancellation |
US20090082651A1 (en) * | 2004-03-08 | 2009-03-26 | Nellcor Puritan Bennett Llc | Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics |
US8611977B2 (en) | 2004-03-08 | 2013-12-17 | Covidien Lp | Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue |
US20050197579A1 (en) * | 2004-03-08 | 2005-09-08 | Nellcor Puritan Bennett Incorporated | Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue |
US7890154B2 (en) | 2004-03-08 | 2011-02-15 | Nellcor Puritan Bennett Llc | Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics |
US8560036B2 (en) | 2004-03-08 | 2013-10-15 | Covidien Lp | Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics |
US20110092785A1 (en) * | 2004-03-08 | 2011-04-21 | Nellcor Puritan Bennett Llc | Selection of Ensemble Averaging Weights for a Pulse Oximeter Based on Signal Quality Metrics |
US8007441B2 (en) | 2004-03-08 | 2011-08-30 | Nellcor Puritan Bennett Llc | Pulse oximeter with alternate heart-rate determination |
US20080009690A1 (en) * | 2004-03-09 | 2008-01-10 | Nellcor Puritan Bennett Llc | Pulse oximetry motion artifact rejection using near infrared absorption by water |
US20070106137A1 (en) * | 2004-03-09 | 2007-05-10 | Baker Clark R Jr | Pulse oximetry signal correction using near infrared absorption by water |
US8195263B2 (en) | 2004-03-09 | 2012-06-05 | Nellcor Puritan Bennett Llc | Pulse oximetry motion artifact rejection using near infrared absorption by water |
US8175670B2 (en) | 2004-03-09 | 2012-05-08 | Nellcor Puritan Bennett Llc | Pulse oximetry signal correction using near infrared absorption by water |
US9351674B2 (en) | 2005-03-03 | 2016-05-31 | Covidien Lp | Method for enhancing pulse oximetry calculations in the presence of correlated artifacts |
US8818475B2 (en) | 2005-03-03 | 2014-08-26 | Covidien Lp | Method for enhancing pulse oximetry calculations in the presence of correlated artifacts |
US8423109B2 (en) | 2005-03-03 | 2013-04-16 | Covidien Lp | Method for enhancing pulse oximery calculations in the presence of correlated artifacts |
US20080255436A1 (en) * | 2005-03-03 | 2008-10-16 | Nellcor Puritain Bennett Incorporated | Method for Enhancing Pulse Oximery Calculations in the Presence of Correlated Artifacts |
US8744543B2 (en) | 2005-09-29 | 2014-06-03 | Covidien Lp | System and method for removing artifacts from waveforms |
US7725147B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for removing artifacts from waveforms |
US7725146B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for pre-processing waveforms |
US20070073124A1 (en) * | 2005-09-29 | 2007-03-29 | Li Li | System and method for removing artifacts from waveforms |
US8364221B2 (en) | 2005-09-30 | 2013-01-29 | Covidien Lp | Patient monitoring alarm escalation system and method |
US8238994B2 (en) | 2005-10-28 | 2012-08-07 | Nellcor Puritan Bennett Llc | Adjusting parameters used in pulse oximetry analysis |
US20090253971A1 (en) * | 2005-10-28 | 2009-10-08 | Nellcor Puritan Bennett Llc | Adjusting parameters used in pulse oximetry analysis |
US8728001B2 (en) | 2006-02-10 | 2014-05-20 | Lawrence A. Lynn | Nasal capnographic pressure monitoring system |
US20100174161A1 (en) * | 2006-02-10 | 2010-07-08 | Lynn Lawrence A | System and method for the detection of physiologic response to stimulation |
US8702606B2 (en) | 2006-03-21 | 2014-04-22 | Covidien Lp | Patient monitoring help video system and method |
US20080214906A1 (en) * | 2006-03-21 | 2008-09-04 | Nellcor Puritan Bennett Llc | Patient Monitoring Help Video System and Method |
US8380271B2 (en) | 2006-06-15 | 2013-02-19 | Covidien Lp | System and method for generating customizable audible beep tones and alarms |
US8538500B2 (en) | 2006-09-20 | 2013-09-17 | Covidien Lp | System and method for probability based determination of estimated oxygen saturation |
US8064975B2 (en) | 2006-09-20 | 2011-11-22 | Nellcor Puritan Bennett Llc | System and method for probability based determination of estimated oxygen saturation |
US20080076986A1 (en) * | 2006-09-20 | 2008-03-27 | Nellcor Puritan Bennett Inc. | System and method for probability based determination of estimated oxygen saturation |
US20080076977A1 (en) * | 2006-09-26 | 2008-03-27 | Nellcor Puritan Bennett Inc. | Patient monitoring device snapshot feature system and method |
US8696593B2 (en) | 2006-09-27 | 2014-04-15 | Covidien Lp | Method and system for monitoring intracranial pressure |
US8801622B2 (en) | 2006-09-28 | 2014-08-12 | Covidien Lp | System and method for pulse rate calculation using a scheme for alternate weighting |
US7922665B2 (en) | 2006-09-28 | 2011-04-12 | Nellcor Puritan Bennett Llc | System and method for pulse rate calculation using a scheme for alternate weighting |
US10022058B2 (en) | 2006-09-28 | 2018-07-17 | Covidien Lp | System and method for pulse rate calculation using a scheme for alternate weighting |
US7698002B2 (en) | 2006-09-29 | 2010-04-13 | Nellcor Puritan Bennett Llc | Systems and methods for user interface and identification in a medical device |
US7925511B2 (en) | 2006-09-29 | 2011-04-12 | Nellcor Puritan Bennett Llc | System and method for secure voice identification in a medical device |
US20080082338A1 (en) * | 2006-09-29 | 2008-04-03 | O'neil Michael P | Systems and methods for secure voice identification and medical device interface |
US20080081974A1 (en) * | 2006-09-29 | 2008-04-03 | Nellcor Puritan Bennett Incorporated | Pathological condition detector using kernel methods and oximeters |
US20080081956A1 (en) * | 2006-09-29 | 2008-04-03 | Jayesh Shah | System and method for integrating voice with a medical device |
US20080082339A1 (en) * | 2006-09-29 | 2008-04-03 | Nellcor Puritan Bennett Incorporated | System and method for secure voice identification in a medical device |
US20080097175A1 (en) * | 2006-09-29 | 2008-04-24 | Boyce Robin S | System and method for display control of patient monitor |
US20080114226A1 (en) * | 2006-09-29 | 2008-05-15 | Doug Music | Systems and methods for user interface and identification in a medical device |
US20080114211A1 (en) * | 2006-09-29 | 2008-05-15 | Edward Karst | System and method for assuring validity of monitoring parameter in combination with a therapeutic device |
US20080189783A1 (en) * | 2006-09-29 | 2008-08-07 | Doug Music | User interface and identification in a medical device system and method |
US8160726B2 (en) | 2006-09-29 | 2012-04-17 | Nellcor Puritan Bennett Llc | User interface and identification in a medical device system and method |
US20080081970A1 (en) * | 2006-09-29 | 2008-04-03 | Nellcor Puritan Bennett Incorporated | Pulse oximetry sensor switchover |
US8160668B2 (en) | 2006-09-29 | 2012-04-17 | Nellcor Puritan Bennett Llc | Pathological condition detector using kernel methods and oximeters |
US8160683B2 (en) | 2006-09-29 | 2012-04-17 | Nellcor Puritan Bennett Llc | System and method for integrating voice with a medical device |
US20110098544A1 (en) * | 2006-09-29 | 2011-04-28 | Nellcor Puritan Bennett Llc | System and method for integrating voice with a medical device |
US7706896B2 (en) | 2006-09-29 | 2010-04-27 | Nellcor Puritan Bennett Llc | User interface and identification in a medical device system and method |
US8728059B2 (en) | 2006-09-29 | 2014-05-20 | Covidien Lp | System and method for assuring validity of monitoring parameter in combination with a therapeutic device |
US7848891B2 (en) | 2006-09-29 | 2010-12-07 | Nellcor Puritan Bennett Llc | Modulation ratio determination with accommodation of uncertainty |
US8068890B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Pulse oximetry sensor switchover |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US20100141391A1 (en) * | 2006-09-29 | 2010-06-10 | Nellcor Puritan Bennett Llc | User interface and identification in a medical device system and method |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US20080200819A1 (en) * | 2007-02-20 | 2008-08-21 | Lynn Lawrence A | Orthostasis detection system and method |
US20080200775A1 (en) * | 2007-02-20 | 2008-08-21 | Lynn Lawrence A | Maneuver-based plethysmographic pulse variation detection system and method |
US20080221427A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US20080221426A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | Methods and apparatus for detecting misapplied optical sensors |
US20090080007A1 (en) * | 2007-09-25 | 2009-03-26 | Brother Kogyo Kabushiki Kaisha | Printing device and method therefor |
US20090154573A1 (en) * | 2007-12-13 | 2009-06-18 | Nellcor Puritan Bennett Llc | Signal Demodulation |
US8204567B2 (en) | 2007-12-13 | 2012-06-19 | Nellcor Puritan Bennett Llc | Signal demodulation |
US20090171167A1 (en) * | 2007-12-27 | 2009-07-02 | Nellcor Puritan Bennett Llc | System And Method For Monitor Alarm Management |
US20090171226A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for evaluating variation in the timing of physiological events |
US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
US20090171166A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | Oximeter with location awareness |
US20090171174A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for maintaining battery life |
US20090171173A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for reducing motion artifacts in a sensor |
US8781753B2 (en) | 2008-02-19 | 2014-07-15 | Covidien Lp | System and method for evaluating physiological parameter data |
US8275553B2 (en) | 2008-02-19 | 2012-09-25 | Nellcor Puritan Bennett Llc | System and method for evaluating physiological parameter data |
US8750953B2 (en) | 2008-02-19 | 2014-06-10 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US11298076B2 (en) | 2008-02-19 | 2022-04-12 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US10076276B2 (en) | 2008-02-19 | 2018-09-18 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US20090210163A1 (en) * | 2008-02-19 | 2009-08-20 | Nellcor Puritan Bennett Llc | System And Method For Evaluating Physiological Parameter Data |
US20090209839A1 (en) * | 2008-02-19 | 2009-08-20 | Nellcor Puritan Bennett Llc | Methods And Systems For Alerting Practitioners To Physiological Conditions |
US11147482B2 (en) | 2008-03-25 | 2021-10-19 | St. Louis Medical Devices, Inc. | Method and system for non-invasive blood glucose measurement using signal change of the non-glucose components induced by the presence of glucose |
US10542919B2 (en) | 2008-03-25 | 2020-01-28 | St. Louis Medical Devices, Inc. | Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose |
US20090247851A1 (en) * | 2008-03-26 | 2009-10-01 | Nellcor Puritan Bennett Llc | Graphical User Interface For Monitor Alarm Management |
US8140272B2 (en) | 2008-03-27 | 2012-03-20 | Nellcor Puritan Bennett Llc | System and method for unmixing spectroscopic observations with nonnegative matrix factorization |
US20090248320A1 (en) * | 2008-03-27 | 2009-10-01 | Nellcor Puritan Benett Llc | System And Method For Unmixing Spectroscopic Observations With Nonnegative Matrix Factorization |
US20090247854A1 (en) * | 2008-03-27 | 2009-10-01 | Nellcor Puritan Bennett Llc | Retractable Sensor Cable For A Pulse Oximeter |
US20090247845A1 (en) * | 2008-03-28 | 2009-10-01 | Nellcor Puritan Bennett Llc | System And Method For Estimating Blood Analyte Concentration |
US20090247850A1 (en) * | 2008-03-28 | 2009-10-01 | Nellcor Puritan Bennett Llc | Manually Powered Oximeter |
US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
US8112375B2 (en) | 2008-03-31 | 2012-02-07 | Nellcor Puritan Bennett Llc | Wavelength selection and outlier detection in reduced rank linear models |
US20090247852A1 (en) * | 2008-03-31 | 2009-10-01 | Nellcor Puritan Bennett Llc | System and method for facilitating sensor and monitor communication |
US8364224B2 (en) | 2008-03-31 | 2013-01-29 | Covidien Lp | System and method for facilitating sensor and monitor communication |
US8292809B2 (en) | 2008-03-31 | 2012-10-23 | Nellcor Puritan Bennett Llc | Detecting chemical components from spectroscopic observations |
US20090247083A1 (en) * | 2008-03-31 | 2009-10-01 | Nellcor Puritan Bennett Llc | Wavelength Selection And Outlier Detection In Reduced Rank Linear Models |
US20090281838A1 (en) * | 2008-05-07 | 2009-11-12 | Lawrence A. Lynn | Medical failure pattern search engine |
US11553859B2 (en) | 2008-05-22 | 2023-01-17 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US11076781B2 (en) | 2008-05-22 | 2021-08-03 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10973442B2 (en) | 2008-05-22 | 2021-04-13 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10959650B2 (en) | 2008-05-22 | 2021-03-30 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10080515B2 (en) * | 2008-05-22 | 2018-09-25 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US10070809B2 (en) * | 2008-05-22 | 2018-09-11 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
US20170143242A1 (en) * | 2008-05-22 | 2017-05-25 | St. Louis Medical Devices, Inc. | Method and system for non-invasive optical blood glucose detection utilizing spectral data analysis |
USD626561S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Circular satseconds indicator and triangular saturation pattern detection indicator for a patient monitor display panel |
US20090327515A1 (en) * | 2008-06-30 | 2009-12-31 | Thomas Price | Medical Monitor With Network Connectivity |
US8862194B2 (en) | 2008-06-30 | 2014-10-14 | Covidien Lp | Method for improved oxygen saturation estimation in the presence of noise |
US20090326335A1 (en) * | 2008-06-30 | 2009-12-31 | Baker Clark R | Pulse Oximeter With Wait-Time Indication |
USD736250S1 (en) | 2008-06-30 | 2015-08-11 | Covidien Lp | Portion of a display panel with an indicator icon |
US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
USD626562S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Triangular saturation pattern detection indicator for a patient monitor display panel |
US8364220B2 (en) | 2008-09-25 | 2013-01-29 | Covidien Lp | Medical sensor and technique for using the same |
US20100076319A1 (en) * | 2008-09-25 | 2010-03-25 | Nellcor Puritan Bennett Llc | Pathlength-Corrected Medical Spectroscopy |
US20100076337A1 (en) * | 2008-09-25 | 2010-03-25 | Nellcor Puritan Bennett Llc | Medical Sensor And Technique For Using The Same |
US8257274B2 (en) | 2008-09-25 | 2012-09-04 | Nellcor Puritan Bennett Llc | Medical sensor and technique for using the same |
US8386000B2 (en) | 2008-09-30 | 2013-02-26 | Covidien Lp | System and method for photon density wave pulse oximetry and pulse hemometry |
US20100081899A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | System and Method for Photon Density Wave Pulse Oximetry and Pulse Hemometry |
US20100081897A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | Transmission Mode Photon Density Wave System And Method |
US8968193B2 (en) | 2008-09-30 | 2015-03-03 | Covidien Lp | System and method for enabling a research mode on physiological monitors |
US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
US20100081890A1 (en) * | 2008-09-30 | 2010-04-01 | Nellcor Puritan Bennett Llc | System And Method For Enabling A Research Mode On Physiological Monitors |
US8433382B2 (en) | 2008-09-30 | 2013-04-30 | Covidien Lp | Transmission mode photon density wave system and method |
US20100113909A1 (en) * | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System And Method For Facilitating Observation Of Monitored Physiologic Data |
US9993208B2 (en) | 2008-10-31 | 2018-06-12 | Covidien Lp | System and method for facilitating observation of monitored physiologic data |
US8622916B2 (en) | 2008-10-31 | 2014-01-07 | Covidien Lp | System and method for facilitating observation of monitored physiologic data |
US20100113908A1 (en) * | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System And Method For Facilitating Observation Of Monitored Physiologic Data |
US20090171172A1 (en) * | 2008-12-19 | 2009-07-02 | Nellcor Puritan Bennett Llc | Method and system for pulse gating |
US20100240972A1 (en) * | 2009-03-20 | 2010-09-23 | Nellcor Puritan Bennett Llc | Slider Spot Check Pulse Oximeter |
US8515515B2 (en) | 2009-03-25 | 2013-08-20 | Covidien Lp | Medical sensor with compressible light barrier and technique for using the same |
US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
US8781548B2 (en) | 2009-03-31 | 2014-07-15 | Covidien Lp | Medical sensor with flexible components and technique for using the same |
US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
US8494786B2 (en) | 2009-07-30 | 2013-07-23 | Covidien Lp | Exponential sampling of red and infrared signals |
US9380969B2 (en) | 2009-07-30 | 2016-07-05 | Covidien Lp | Systems and methods for varying a sampling rate of a signal |
US20110029865A1 (en) * | 2009-07-31 | 2011-02-03 | Nellcor Puritan Bennett Llc | Control Interface For A Medical Monitor |
US8494606B2 (en) | 2009-08-19 | 2013-07-23 | Covidien Lp | Photoplethysmography with controlled application of sensor pressure |
US8494604B2 (en) | 2009-09-21 | 2013-07-23 | Covidien Lp | Wavelength-division multiplexing in a multi-wavelength photon density wave system |
US8704666B2 (en) | 2009-09-21 | 2014-04-22 | Covidien Lp | Medical device interface customization systems and methods |
US20110071373A1 (en) * | 2009-09-21 | 2011-03-24 | Nellcor Puritan Bennett Llc | Time-Division Multiplexing In A Multi-Wavelength Photon Density Wave System |
US8788001B2 (en) | 2009-09-21 | 2014-07-22 | Covidien Lp | Time-division multiplexing in a multi-wavelength photon density wave system |
US20110071368A1 (en) * | 2009-09-21 | 2011-03-24 | Nellcor Puritan Bennett Llc | Medical Device Interface Customization Systems And Methods |
US20110071371A1 (en) * | 2009-09-21 | 2011-03-24 | Nellcor Puritan Bennett Llc | Wavelength-Division Multiplexing In A Multi-Wavelength Photon Density Wave System |
US8855749B2 (en) | 2009-09-24 | 2014-10-07 | Covidien Lp | Determination of a physiological parameter |
US8798704B2 (en) | 2009-09-24 | 2014-08-05 | Covidien Lp | Photoacoustic spectroscopy method and system to discern sepsis from shock |
US8571621B2 (en) | 2009-09-24 | 2013-10-29 | Covidien Lp | Minimax filtering for pulse oximetry |
US20110071598A1 (en) * | 2009-09-24 | 2011-03-24 | Nellcor Puritan Bennett Llc | Photoacoustic Spectroscopy Method And System To Discern Sepsis From Shock |
US20110071376A1 (en) * | 2009-09-24 | 2011-03-24 | Nellcor Puritan Bennett Llc | Determination Of A Physiological Parameter |
US8923945B2 (en) | 2009-09-24 | 2014-12-30 | Covidien Lp | Determination of a physiological parameter |
US20110071366A1 (en) * | 2009-09-24 | 2011-03-24 | Nellcor Puritan Bennett Llc | Determination Of A Physiological Parameter |
US8515511B2 (en) | 2009-09-29 | 2013-08-20 | Covidien Lp | Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same |
US9597023B2 (en) | 2009-09-29 | 2017-03-21 | Covidien Lp | Oximetry assembly |
US20110077547A1 (en) * | 2009-09-29 | 2011-03-31 | Nellcor Puritan Bennett Llc | Spectroscopic Method And System For Assessing Tissue Temperature |
US8376955B2 (en) | 2009-09-29 | 2013-02-19 | Covidien Lp | Spectroscopic method and system for assessing tissue temperature |
US9585606B2 (en) | 2009-09-29 | 2017-03-07 | Covidien Lp | Oximetry assembly |
US20110077470A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Patient Monitor Symmetry Control |
US8401608B2 (en) | 2009-09-30 | 2013-03-19 | Covidien Lp | Method of analyzing photon density waves in a medical monitor |
US20110077485A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Method Of Analyzing Photon Density Waves In A Medical Monitor |
US20110074342A1 (en) * | 2009-09-30 | 2011-03-31 | Nellcor Puritan Bennett Llc | Wireless electricity for electronic devices |
US10241033B2 (en) | 2010-03-05 | 2019-03-26 | Seiko Epson Corporation | Spectroscopic sensor device and electronic equipment |
US8391943B2 (en) | 2010-03-31 | 2013-03-05 | Covidien Lp | Multi-wavelength photon density wave system using an optical switch |
US8498683B2 (en) | 2010-04-30 | 2013-07-30 | Covidien LLP | Method for respiration rate and blood pressure alarm management |
US8930145B2 (en) | 2010-07-28 | 2015-01-06 | Covidien Lp | Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring |
US9380982B2 (en) | 2010-07-28 | 2016-07-05 | Covidien Lp | Adaptive alarm system and method |
US8610769B2 (en) | 2011-02-28 | 2013-12-17 | Covidien Lp | Medical monitor data collection system and method |
US9833146B2 (en) | 2012-04-17 | 2017-12-05 | Covidien Lp | Surgical system and method of use of the same |
CN104068865A (en) * | 2014-04-24 | 2014-10-01 | 辛勤 | Oxyhemoglobin saturation measuring method and portable device |
CN105286883A (en) * | 2015-09-11 | 2016-02-03 | 蚌埠医学院 | Pulse hemoglobin concentration non-invasive measurement method and device |
Also Published As
Publication number | Publication date |
---|---|
US6183414B1 (en) | 2001-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6708048B1 (en) | Phase modulation spectrophotometric apparatus | |
EP0689398B1 (en) | Pathlength corrected oximeter | |
US20030023140A1 (en) | Pathlength corrected oximeter and the like | |
US6263221B1 (en) | Quantitative analyses of biological tissue using phase modulation spectroscopy | |
US6246892B1 (en) | Phase modulation spectroscopy | |
Chance et al. | Phase measurement of light absorption and scatter in human tissue | |
US5187672A (en) | Phase modulation spectroscopic system | |
US6714805B2 (en) | Method and apparatus for noninvasively monitoring hemoglobin concentration and oxygen saturation | |
US8606342B2 (en) | Pulse and active pulse spectraphotometry | |
CA2494030C (en) | Method for spectrophotometric blood oxygenation monitoring | |
US5553614A (en) | Examination of biological tissue using frequency domain spectroscopy | |
US5137023A (en) | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography | |
JP3433498B2 (en) | Method and apparatus for measuring internal information of scattering medium | |
Lindberg et al. | Photoplethysmography: Part 2 influence of light source wavelength | |
JP3844815B2 (en) | Method and apparatus for measuring absorption information of scatterers | |
JP3619969B2 (en) | Light sensor with multiple light sources | |
US5419321A (en) | Non-invasive medical sensor | |
US7236813B2 (en) | Optical device | |
US5513642A (en) | Reflectance sensor system | |
JP3247694B2 (en) | Time and frequency domain spectrometer for measuring hypoxia | |
RU2040912C1 (en) | Optical method and device for determining blood oxygenation | |
JP3359756B2 (en) | Biological light measurement device | |
GB2244128A (en) | Non-invasive medical sensor | |
Bal et al. | The determination of absorption and reduced scattering coefficients of optical phantoms using a frequency-domain multi-distance method in a non-contact manner | |
JPH1082732A (en) | Optical measuring equipment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |